CD274 and neoplasm: Doxorubicin can not only stimulate the anti-tumor immune response by inducing immunogenic cell death (71), it also up-regulated the expression of PD-L1 in both the clinical osteosarcoma tissue samples and the osteosarcoma cell lines (72, 73).